Hypertension in adult polycystic kidney disease: a narrative review

被引：0
|
作者：
Mian, Sarah [1 ]
Acharya, Yogesh [1 ]
Dahal, Ranjan [2 ]
机构：
[1] Avalon Univ, Sch Med, Curacao, Neth Antilles
[2] St Peters Univ Hosp, New Brunswick, NJ 08901 USA
来源：
JOURNAL OF RENAL INJURY PREVENTION | 2019年 / 8卷 / 02期
关键词：
Adult polycystic kidney disease; Hypertension; Antihypertensive agents; Prevention and control; Renin-angiotensin-aldosterone system; End stage renal disease; Glomerular filtration rate; Chronic kidney disease; CONVERTING-ENZYME-INHIBITORS; BLOOD-PRESSURE; ENDOTHELIN; PROGRESSION; ADPKD;
D O I：
10.15171/jrip.2019.23
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Autosomal dominant polycystic kidney disease (ADPKD) is an inherited renal disorder that impacts approximately 12 million worldwide. It is characterized by bilateral kidney enlargement and cystic growth. Hypertension (HTN) is a focal point in the management of ADPKD and is linked to a faster progression to end stage renal disease. Current novel therapies have proven to reduce the progression of renal damage. The ideal goal is to minimize risk through preventative studies and pharmacology to further increase life expectancy and quality. The purpose of this article is to highlight the importance of blood pressure management in ADPKD and review current literature to determine the most effective preventative pharmacotherapy.
引用
收藏
页码：122 / 126
页数：5
相关论文
共 50 条
  • [1] Diet and Physical Activity in Adult Dominant Polycystic Kidney Disease: A Review of the Literature
    Capelli, Irene
    Lerario, Sarah
    Aiello, Valeria
    Provenzano, Michele
    Di Costanzo, Roberta
    Squadrani, Andrea
    Vella, Anna
    Vicennati, Valentina
    Poli, Carolina
    La Manna, Gaetano
    Baraldi, Olga
    NUTRIENTS, 2023, 15 (11)
  • [2] Update and review of adult polycystic kidney disease
    Colbert, Gates B.
    Elrggal, Mohamed E.
    Gaur, Lovy
    Lerma, Edgar, V
    DM DISEASE-A-MONTH, 2020, 66 (05):
  • [3] Adult Polycystic Kidney Disease: Who Needs Hospital Follow-Up?
    Griveas, Ioannis
    Bishop, Kathryn
    World, Michael
    ARTIFICIAL ORGANS, 2012, 36 (07) : 594 - 599
  • [4] Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease
    Rahbari-Oskoui, Frederic
    Williams, Olubunmi
    Chapman, Arlene
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (12) : 2194 - 2201
  • [5] Effect of early postnatal nutrition on chronic kidney disease and arterial hypertension in adulthood: a narrative review
    Juvet, C.
    Simeoni, U.
    Yzydorczyk, C.
    Siddeek, B.
    Armengaud, J. -B.
    Nardou, K.
    Juvet, P.
    Benahmed, M.
    Cachat, F.
    Chehade, H.
    JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, 2018, 9 (06) : 598 - 614
  • [6] Review - current opinion in cardiology hypertension in chronic kidney disease
    Alqudsi, Muhannad
    Hiremath, Swapnil
    Velez, Juan Carlos Q.
    CURRENT OPINION IN CARDIOLOGY, 2020, 35 (04) : 360 - 367
  • [7] The pathogenesis of hypertension in autosomal dominant polycystic kidney disease
    Wang, D
    Strandgaard, S
    JOURNAL OF HYPERTENSION, 1997, 15 (09) : 925 - 933
  • [8] SPRINT-A Kidney-Centric Narrative Review Recent Advances in Hypertension
    Hu, Austin H.
    Chang, Tara I.
    HYPERTENSION, 2021, 78 (04) : 946 - 954
  • [9] Hypertension in young adults with autosomal dominant polycystic kidney disease: a case for early screening?
    Cadnapaphornchai, Melissa A.
    Ong, Albert C. M.
    CLINICAL KIDNEY JOURNAL, 2023, 16 (06) : 901 - 904
  • [10] Hypertension in autosomal dominant polycystic kidney disease
    Chapman, AB
    Gabow, PA
    KIDNEY INTERNATIONAL, 1997, : S71 - S73
12345